Audit 397630

FY End
2025-06-30
Total Expended
$8.60M
Findings
19
Programs
8
Year: 2025 Accepted: 2026-04-03
Auditor: LEAF & COLE LLP

Organization Exclusion Status:

Checking exclusion status...

Findings

ID Ref Severity Repeat Requirement
1205860 2025-001 Material Weakness Yes C
1205861 2025-001 Material Weakness Yes C
1205862 2025-001 Material Weakness Yes C
1205863 2025-001 Material Weakness Yes C
1205864 2025-001 Material Weakness Yes C
1205865 2025-001 Material Weakness Yes C
1205866 2025-001 Material Weakness Yes C
1205867 2025-001 Material Weakness Yes C
1205868 2025-001 Material Weakness Yes C
1205869 2025-001 Material Weakness Yes C
1205870 2025-001 Material Weakness Yes C
1205871 2025-001 Material Weakness Yes C
1205872 2025-001 Material Weakness Yes C
1205873 2025-001 Material Weakness Yes C
1205874 2025-001 Material Weakness Yes C
1205875 2025-001 Material Weakness Yes C
1205876 2025-001 Material Weakness Yes C
1205877 2025-001 Material Weakness Yes C
1205878 2025-001 Material Weakness Yes C

Programs

ALN Program Spent Major Findings
93.279 DRUG USE AND ADDICTION RESEARCH PROGRAMS $673,425 Yes 1
93.393 CANCER CAUSE AND PREVENTION RESEARCH $556,868 Yes 1
93.113 ENVIRONMENTAL HEALTH $485,887 Yes 1
93.853 EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS $442,080 Yes 1
93.310 TRANS-NIH RESEARCH SUPPORT $397,362 Yes 1
93.866 AGING RESEARCH $243,226 Yes 1
93.859 BIOMEDICAL RESEARCH AND RESEARCH TRAINING $240,466 Yes 1
93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH $221,290 Yes 1

Contacts

Name Title Type
ZM3DYHAGMKM3 Christine Auciello Auditee
8582007156 Jill Branch Auditor
No contacts on file

Notes to SEFA

The accompanying schedule of expenditures of federal awards (the Schedule) includes the federal award activity of San Diego Biomedical Research Institute under programs of the federal government for the year ended June 30, 2025. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a selected portion of the operations of San Diego Biomedical Research Institute, it is not intended to and does not present the financial position, changes in net assets, or cash flows of San Diego Biomedical Research Institute.
Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. San Diego Biomedical Research Institute has elected not to use the de minimis indirect cost rate as allowed under Uniform Guidance.

Finding Details

U.S. Department of Health and Human Services Research and Development Cluster – 93.RD Condition Funds were drawn down by the Institute in excess of the three-day period recommended by its funding agency and did not minimize the time elapsing between the transfers of funds from the grantor to the issue of payment by the recipient during the year ended June 30, 2025. Criteria Cash management under 2 CFR 215.22 states that payment methods shall minimize the time elapsing between the transfers of funds from the grantor to the issue of payment by the recipient. Cause The Institute’s preparation and review procedures over the drawdown of funds were insufficient to minimize the time elapsing between the transfers of funds from the grantor to the issue of payments by the Institute. Effect The Institute was not in compliance with the cash management compliance requirements stated in 2 CFR 215.22 during the year and the Institute had an overdrawn balance of $719,817 at June 30, 2025. Recommendation The Institute should improve its procedures over advances of federal funds. Management Response Management acknowledges the finding regarding the timing of federal fund drawdowns and the requirements under 2 CFR 215.22 to minimize the time between receipt of federal funds and the disbursement of those funds for allowable program costs. The Institute recognizes the importance of maintaining compliance with federal cash management requirements and ensuring that drawdowns are aligned as closely as possible with immediate funding needs. Management has enhanced its oversight of federal cash management processes to ensure that drawdowns are closely aligned with actual expenditures and immediate cash needs in accordance with 2 CFR 215.22. Additional review procedures for drawdown requests have been implemented, and regular monitoring of grant expenditure and cash balances has been incorporated into the Institute’s ongoing financial management and oversight activities.